Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefuroxime
Drug ID BADD_D00407
Description Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
Indications and Usage For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
Marketing Status approved
ATC Code J01DC02; S01AA27
DrugBank ID DB01112
KEGG ID D00262
MeSH ID D002444
PubChem ID 41375
TTD Drug ID D0Y2IE
NDC Product Code 0143-9567; 0143-9569; 0143-9976; 0143-9568; 0143-9977; 0143-9979
UNII O1R9FJ93ED
Synonyms Cefuroxime | Cephuroxime | Zinacef | Ketocef
Chemical Information
Molecular Formula C16H16N4O8S
CAS Registry Number 55268-75-2
SMILES CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Musculoskeletal discomfort15.03.04.001---
Secretion discharge08.01.03.019---
Type IV hypersensitivity reaction10.01.03.0220.000572%-
Anterior chamber cell06.04.10.0010.000143%-
Nodule08.03.05.0020.000215%-
Skin candida11.03.03.010; 23.11.03.009---
Dental discomfort07.09.06.0020.000143%-
Anterior chamber inflammation06.04.10.0020.001645%-
Skin burning sensation17.02.06.009; 23.03.03.0210.000630%-
Haemorrhage24.07.01.002---
Vulvovaginal pruritus21.08.02.004; 23.03.12.009---
Paraesthesia oral07.05.05.035; 17.02.06.0080.000143%-
Anterior chamber pigmentation06.06.07.0010.001216%-
Cystoid macular oedema06.04.06.010; 12.02.02.0050.000930%-
Retroperitoneal haematoma07.07.02.005; 24.07.01.0600.000143%-
Angiopathy24.03.02.007---
Blood alkaline phosphatase increased13.04.02.004--
Drug resistance08.06.01.0050.000787%-
Hepatic enzyme increased13.03.04.028---
Appetite disorder14.03.01.004; 19.09.01.0020.000143%-
Coombs test positive13.01.01.002---
Ocular toxicity06.11.01.006; 12.03.01.0310.002947%-
Infestation11.09.01.001; 23.11.01.002---
Limb discomfort15.03.04.0140.000486%-
Partial seizures17.12.03.0100.000215%-
Decreased appetite08.01.09.028; 14.03.01.005--
Sensation of foreign body08.01.09.0020.000143%-
Blood disorder01.05.01.004---
Psychotic disorder19.03.01.0020.000215%
Hepatobiliary disease09.01.08.003---
The 11th Page    First    Pre   11 12 13    Next   Last    Total 13 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene